Please login to the form below

Not currently logged in
Email:
Password:

European Society of Cardiology launches AF patient website

Partners with European Heart Rhythm Association

AFMatters

The European Society of Cardiology (ESC) has launched an atrial fibrillation (AF) patient website in collaboration with the European Heart Rhythm Association (EHRA).

AFib Matters was created by a multidisciplinary task force of clinicians and patient representatives, in order to provide information about the heart condition; detailing the different types of AF, its causes, the symptoms and treatment options.

The University of Birmingham's professor Gregory YH Lip, who chaired the development of the project, said: “It is the authoritative website on atrial fibrillation and will be updated at regular intervals with relevant and timely information.

“The website also highlights the latest developments in the treatment and management of atrial fibrillation, including the new oral anticoagulant drugs, ablation and devices.

“We know that education on atrial fibrillation helps patients understand their condition and improves management. AFib Matters will boost awareness and understanding of atrial fibrillation and dispel misconceptions of this common and distressing condition.”

As the most common cardiac rhythm disorder, AF affects more than six million people across Europe and this figure expected to double over the next 50 years as the population ages. People with the condition have an increased risk of stroke, heart failure and impaired cognitive function, including dementia.

The website goes live this week to coincide with the EHRA's biannual Europace meeting, which is currently taking place in Greece.  

24th June 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics